- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.50 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NDP.2: 19 residues within 4Å:- Chain A: K.80, G.216, G.217, Y.218, I.219, E.222, Y.241, R.242, R.248, N.274, A.304, I.305, G.306, R.307, M.353, L.354, A.385, F.387
- Ligands: FAD.1
15 PLIP interactions:15 interactions with chain A- Hydrophobic interactions: A:Y.218, A:Y.218, A:I.219
- Hydrogen bonds: A:K.80, A:G.216, A:G.216, A:G.217, A:I.219, A:Y.241, A:Y.241, A:N.274, A:A.385
- Salt bridges: A:R.242
- pi-Cation interactions: A:R.242, A:R.242
NDP.8: 19 residues within 4Å:- Chain B: K.80, G.216, G.217, Y.218, I.219, E.222, Y.241, R.242, R.248, N.274, A.304, I.305, G.306, R.307, M.353, L.354, A.385, F.387
- Ligands: FAD.7
14 PLIP interactions:14 interactions with chain B- Hydrophobic interactions: B:Y.218, B:Y.218, B:I.219
- Hydrogen bonds: B:K.80, B:G.216, B:G.216, B:Y.218, B:I.219, B:Y.241, B:N.274, B:A.385
- Salt bridges: B:R.242
- pi-Cation interactions: B:R.242, B:R.242
- 2 x AU: GOLD ION(Non-covalent)
AU.3: 5 residues within 4Å:- Chain A: C.72, C.77, T.355
- Chain B: H.481
- Ligands: CL.5
2 PLIP interactions:2 interactions with chain A- Metal complexes: A:C.72, A:C.77
AU.9: 5 residues within 4Å:- Chain A: H.481
- Chain B: C.72, C.77, T.355
- Ligands: CL.11
2 PLIP interactions:2 interactions with chain B- Metal complexes: B:C.72, B:C.77
- 2 x TS8: 2,3,4,6-tetra-O-acetyl-1-thio-beta-D-glucopyranose(Non-covalent)
TS8.4: 9 residues within 4Å:- Chain B: F.416, L.419, H.481, P.482, T.483, E.486, E.487
- Ligands: CL.5, SO4.12
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:F.416, B:L.419
- Hydrogen bonds: B:T.483, B:E.486
- Salt bridges: B:H.481, B:H.481
TS8.10: 9 residues within 4Å:- Chain A: F.416, T.417, L.419, H.481, P.482, E.486, E.487
- Ligands: SO4.6, CL.11
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:F.416, A:L.419
- Salt bridges: A:H.481, A:H.481
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x SO4: SULFATE ION(Non-functional Binders)
SO4.6: 7 residues within 4Å:- Chain A: P.418, L.419, P.482, T.483, S.484
- Chain B: K.81
- Ligands: TS8.10
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:L.419, A:S.484
- Salt bridges: B:K.81
SO4.12: 8 residues within 4Å:- Chain A: K.81
- Chain B: F.416, P.418, L.419, P.482, T.483, S.484
- Ligands: TS8.4
2 PLIP interactions:1 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:L.419
- Salt bridges: A:K.81
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ilari, A. et al., A Gold-Containing Drug Against Parasitic Polyamine Metabolism: The X-Ray Structure of Trypanothione Reductase from Leishmania Infantum in Complex with Auranofin Reveals a Dual Mechanism of Enzyme Inhibition. Amino Acids (2012)
- Release Date
- 2012-01-11
- Peptides
- TRYPANOTHIONE REDUCTASE: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.50 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 2 x AU: GOLD ION(Non-covalent)
- 2 x TS8: 2,3,4,6-tetra-O-acetyl-1-thio-beta-D-glucopyranose(Non-covalent)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ilari, A. et al., A Gold-Containing Drug Against Parasitic Polyamine Metabolism: The X-Ray Structure of Trypanothione Reductase from Leishmania Infantum in Complex with Auranofin Reveals a Dual Mechanism of Enzyme Inhibition. Amino Acids (2012)
- Release Date
- 2012-01-11
- Peptides
- TRYPANOTHIONE REDUCTASE: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B